Copay assistance fund status, eligibility, and covered drugs — for patient access and billing teams.
Maximum award Up to $14,400/year · Income ≤500% FPL · Copay/coinsurance/deductible for covered MDS medications
Published terms from the foundation. Per-patient eligibility and amounts are confirmed at application.
D46.0 D46.1 D46.20 D46.21 D46.22 D46.4 D46.9 D46.A D46.B D46.C D46.ZDrugs whose J-codes this fund matches. Each links to its billing & coding reference.
Fund status changes with donations, often without an announcement — confirm directly with the foundation at 866-316-7263, and check the alternatives below.
Manufacturer copay programs may also apply — see the drug pages: Reblozyl.
Status shown as of each fund's last verification.
As of May 2, 2026, the PAN Foundation Myelodysplastic Syndromes fund is CLOSED to new applications. Fund status changes with donations — call the foundation to confirm before turning a patient away. Verify at time of service: 866-316-7263.
Up to $14,400/year. Copay/coinsurance/deductible for covered MDS medications
Household income must be ≤500% FPL. US resident.
Accepted: medicare, commercial. Not eligible: medicaid.